Login Register Cart 0
Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Impact of Novel Coronavirus (COVID-19) on Pregnant Women: A Review

Author(s): Saima Habeeb* and Manju Chugani

Volume 3, Issue 4, 2022

Published on: 02 June, 2022

Article ID: e030122188011 Pages: 3

DOI: 10.2174/2666796701999201116123457

Abstract

The novel coronavirus infection (COVID-19) is a global public health emergency. Since its outbreak in Wuhan, China in December 2019, the infection has spread at an alarming rate across the globe and humans have been locked down to their countries, cities and homes. As of now, the virus has affected over 20 million people globally and has inflicted over 7 lac deaths. Nevertheless, the recovery rate is improving with each passing day and over 14 million people have recuperated so far. The statistics indicate that nobody is immune to the disease as the virus continues to spread among all age groups, newborns to the elders, and all compartments including pregnant women. However, pregnant women may be more susceptible to this infection as they are, in general, highly vulnerable to respiratory infections. There is no evidence for vertical transmission of the COVID-19 virus among pregnant women, but an increased prevalence of preterm deliveries. Besides this, the COVID-19 may alter immune response at the maternal-fetal interface and affect the well-being of mothers as well as infants. Unfortunately, there is limited evidence available in the open literature regarding coronavirus infection during pregnancy and it now appears that certain pregnant women have been infected during the present 2019-nCoV pandemic. In this perspective, we study the impact of the COVID-19 infection on vertical transmission and fetal outcomes among pregnant women.

Keywords: COVID-19, pregnancy, SARS, MERS, clinical manifestation, vertical transmission, fetal outcome.

[1]
WHO. Coronavirus disease 2019 (COVID-19) situation report 53 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200313-sitrep-53-covid-19.pdf
[2]
Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020; 92(4): 418-23.
[http://dx.doi.org/10.1002/jmv.25681] [PMID: 31967327]
[3]
Ge XY, Li JL, Yang XL, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013; 503(7477): 535-8.
[http://dx.doi.org/10.1038/nature12711] [PMID: 24172901]
[4]
Wang LF, Shi Z, Zhang S, Field H, Daszak P, Eaton BT. Review of bats and SARS. Emerg Infect Dis 2006; 12(12): 1834-40.
[http://dx.doi.org/10.3201/eid1212.060401] [PMID: 17326933]
[5]
Cauchemez S, Van Kerkhove MD, Riley S, Donnelly CA, Fraser C, Ferguson NM. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill 2013; 18(24): 20503.
[PMID: 23787162]
[6]
Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191(1): 292-7.
[http://dx.doi.org/10.1016/j.ajog.2003.11.019] [PMID: 15295381]
[7]
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020; 395(10224): 565-74.
[http://dx.doi.org/10.1016/S0140-6736(20)30251-8] [PMID: 32007145]
[8]
Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol Infect 2019; 52(3): 501-3.
[http://dx.doi.org/10.1016/j.jmii.2018.04.005] [PMID: 29907538]
[9]
Siston AM, Rasmussen SA, Honein MA, et al. Pandemic H1N1 Influenza in Pregnancy Working Group. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303(15): 1517-25.
[http://dx.doi.org/10.1001/jama.2010.479] [PMID: 20407061]
[10]
Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 2020; 395(10226): 809-15.
[http://dx.doi.org/10.1016/S0140-6736(20)30360-3] [PMID: 32151335]
[11]
Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet 2020; 395(10226): 760-2.
[http://dx.doi.org/10.1016/S0140-6736(20)30365-2] [PMID: 32151334]
[12]
Chen Y, Li Z, Zhang YY, Zhao WH, Yu ZY. Maternal health care management during the outbreak of coronavirus disease 2019. J Med Virol 2020; 92(7): 731-9.
[http://dx.doi.org/10.1002/jmv.25787] [PMID: 32219871]
[13]
Dasharaath P, Jeslyn WJ, Karen LM, et al. Coronavirus disease 2019 (COVID-19): Pandemic and pregnancy. Am J Obstet Gynecol 2020; 222(6): 521-531.
[14]
Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants and maternal fetal transmission of SARS-CoV-2: Maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020; 144(7): 799-805.
[http://dx.doi.org/10.5858/arpa.2020-0901-SA] [PMID: 32180426]
[15]
Schwartz DA, Graham AL. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020; 12(2): 194.
[http://dx.doi.org/10.3390/v12020194] [PMID: 32050635]
[16]
Chen S, Liao E, Cao D, Gao Y, Sun G, Shao Y. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia. J Med Virol 2020; 92(9): 1556-1561.
[http://dx.doi.org/10.1002/jmv.25789] [PMID: 32222119]
[17]
Chen Y, Peng H, Wang L, et al. Infants born to mothers with new coronavirus (COVID-19). FrontPediat 2020.
[18]
Yu N, Li W, Kang Q, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. Lancet Infect Dis 2020; 20(5): 559-64.
[http://dx.doi.org/10.1016/S1473-3099(20)30176-6] [PMID: 32220284]
[19]
Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 2020; 395(10226): 809-15.
[20]
Guillaume F, Léo P, Didier M, David B. 2019-nCoV epidemic: What about pregnancies? Lancet 2019; 395(10224): e40.

Rights & Permissions Print Cite
Article Metrics
16
2
© 2024 Bentham Science Publishers | Privacy Policy